CIFR
Cipher Mining Inc.
There isn't enough reported data to score CIFR yet.
MDBH
MDB Capital Holdings, LLC Class A common
There isn't enough reported data to score MDBH yet.
CIFR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
CIFR's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIFR.
MDBH Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
MDBH's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like MDBH.
CIFR PE Valuation
CIFR has no meaningful PE right now: it lost money over the past year.
MDBH PE Valuation
MDBH has no meaningful PE right now: it lost money over the past year.
CIFR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CIFR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MDBH Forward outlook
There aren't enough analyst estimates for MDBH to show an outlook.
CIFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.06 | -$2.86 |
| Q2 2026 | -$2.85 | -$2.40 |
| Q1 2026 | -$2.32 | -$1.94 |
| Q4 2025 | -$2.15 | -$2.01 |
| Q3 2025 | -$0.20 | -$0.07 |
| Q2 2025 | -$0.45 | -850% |
| Q1 2025 | -$0.38 | -733% |
| Q4 2024 | -$0.14 | -$0.04 |
CIFR lost $3.06 per share over the past year, and its loss has widened in each of the last four quarters.
MDBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$4.03 | -553% |
| Q1 2026 | -$3.14 | -349% |
| Q4 2025 | -$2.57 | -325% |
| Q3 2025 | $0.81 | +$3.48 |
| Q2 2025 | $0.89 | +$3.43 |
| Q1 2025 | $1.26 | +$2.89 |
| Q4 2024 | $1.14 | +$2.21 |
| Q3 2024 | -$2.67 | -$2.14 |
MDBH has the edge over CIFR on earnings, with more consistent year-over-year improvement.
CIFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.7M | -63% |
| Q2 2026 | $24.8M | -43% |
| Q1 2026 | $34.8M | -29% |
| Q4 2025 | $59.7M | +41% |
| Q3 2025 | $71.7M | +198% |
| Q2 2025 | $43.6M | +18% |
| Q1 2025 | $49M | +1.7% |
| Q4 2024 | $42.2M | -2.8% |
CIFR's revenue has slid since its 2025 peak: $27M last quarter, down 63% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -269% | -217 points |
| Q2 2026 | -316% | -212 points |
| Q1 2026 | -329% | -251 points |
| Q4 2025 | -503% | -544 points |
| Q3 2025 | -52% | +327 points |
| Q2 2025 | -104% | -60 points |
| Q1 2025 | -78% | -175 points |
| Q4 2024 | 40% | +4 points |
CIFR's operating margin was −269% last quarter, down 217 points from the same quarter a year ago.
MDBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.1M | +134% |
MDBH has the edge over CIFR in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -134% | +612 points |
| Q4 2024 | -746% | N/A |
| Q4 2022 | -81% | N/A |
CIFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.7B | -$1.4B |
| Q2 2026 | -$653.8M | -$566.3M |
| Q1 2026 | -$462.5M | -$390.7M |
| Q4 2025 | -$280.3M | -$204.2M |
| Q3 2025 | -$256.2M | -$173.1M |
| Q2 2025 | -$87.5M | -$54.3M |
| Q1 2025 | -$71.8M | -$37.3M |
| Q4 2024 | -$76.1M | +$38M |
MDBH has the stronger cash trend. Its trailing FCF is up 14% versus its history, compared with CIFR at down 974%.
MDBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.4M | -699% |
| Q4 2024 | $229.3K | +$2.4M |
| Q3 2024 | -$2.1M | -$377.2K |
| Q1 2024 | -$2.4M | -$1.2M |
| Q4 2023 | -$2.1M | -$1.3M |
| Q3 2023 | -$1.7M | +$671.1K |
| Q1 2023 | -$1.2M | +$135.2K |
| Q4 2022 | -$813.6K | +$4.3M |
MDBH's free cash flow was −$7M over the past year, against −$11M the year before. Free cash flow isn't a meaningful measure for financial services companies like MDBH.
CIFR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q1 2025 | 125.4x | High |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | -0.7x | Net Cash |
| Q2 2024 | -1.2x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -2.2x | Net Cash |
| Q2 2023 | -0.1x | Net Cash |
CIFR has the edge over MDBH on leverage, with a lower net debt burden relative to earnings.
MDBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
MDBH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MDBH.
CIFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 7.8 | Oversold |
CIFR's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
MDBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 30.6 | Neutral |
MDBH's weekly RSI is 36 (neutral) and its Stochastic is 31 (neutral).
CIFR PE vs Financial Services Sector
| Metric | CIFR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
CIFR has no meaningful PE right now: it lost money over the past year.
MDBH PE vs Financial Services Sector
| Metric | MDBH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MDBH has no meaningful PE right now: it lost money over the past year.
CIFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 33% below |
| 20 week MA | $15.5 | 54% below |
| 50 week MA | $17.0 | 58% below |
| 100 week MA | $12.2 | 41% below |
| 200 week MA | $7.86 | 9% below |
MDBH has stronger trend alignment. CIFR is above 0 of 5 weekly averages versus MDBH above 0 of 4.
MDBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.94 | 2.1% below |
| 20 week MA | $2.59 | 27% below |
| 50 week MA | $3.03 | 37% below |
| 100 week MA | $3.90 | 51% below |
MDBH is in a downtrend: it's below all four of its weekly moving averages, and 51% below its 100-week average.
CIFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.92 | $9.95 | +0.3% |
| 2021 | $9.95 | $5.21 | -48% |
| 2022 | $5.21 | $0.54 | -90% |
| 2023 | $0.54 | $4.13 | +665% |
| 2024 | $4.13 | $4.86 | +18% |
| 2025 | $4.86 | $15.2 | +213% |
| 2026 YTD | $15.2 | $7.15 | -53% |
CIFR's yearly returns have swung widely, from +665% in 2023 to −90% in 2022. It's down 53% so far in 2026.
MDBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $10.5 | $11.5 | +9.8% |
| 2024 | $11.5 | $6.89 | -40% |
| 2025 | $6.89 | $3.50 | -49% |
| 2026 YTD | $3.50 | $1.90 | -46% |
MDBH has the edge over CIFR on returns for 2026, with the stronger performance.